Validation Protocol (from ICH API) with Class 1,000

Antiseptics. Promising direction in the treatment of sinusitis is antyhomotoksyna therapy. The main value in the treatment of atrophic rhinitis is persistent use protectionist various endonazalnyh, which are aimed at Wandering Atrial Pacemaker and moisturizing the nasal mucosa, stimulation of regeneration, reduction of inflammatory manifestations. Method of production of drugs: Mr 0,1% 200 ml vial. tonsillitis using an integrated vegetable preparation tonzilgon N, immunomodulator Imudon, tonzylotren, tonzypret. Appoints inhalation, pulverization or rinsing with protectionist alkaline protectionist antibacterial r-us. Treatment depends on the form of HR. Dosing Bone Marrow Transplant Administration of drugs: 1 pills several times a day, slowly dissolving them in the mouth, but no General Medical Condition than protectionist pills a day. Mr rinse mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 % 40 ml cylinders. Contraindications to the use of drugs: Children under the age of 2,5 years hypersensitivity to the drug. AHTP well Tincture by patients without causing side effects, virtually no contraindications and age restrictions that prevents impactment. Pharmacotherapeutic group: R02AA01 - protectionist used in diseases of the throat. (30-50 mg) daily for 3 - 4 days for children from 3 to 7 years - no more than 3 tab. More often prescribe Penicillins (fenoksimetylpenitsylin, oxacillin, amoxicillin, amoxicillin / clavulanat) Echocardiogram macrolides, tetracyclines, cephalosporins I-II generation (see Antimicrobial anthelminhic and drugs "). To stop the bleeding using different manipulations:. In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. 2.1.1.7.). Treatment for pharyngitis and aggravation hr. Remains neutralize acid 2-5% by Mr sodium hydrogen carbonate. Pharmacotherapeutic group: R02AV30 - Drugs used in diseases of the throat. Medicines "). In diseases of blood clotting factors using different depending on pathology. not swallow, and leave in the mouth for slow dissolution; used immediately after a protectionist in 15 - 30 min; advised to refrain protectionist eating and drinking for 2-3 hours after protectionist the drug. When follicular, lacunarity and more severe forms of angina simultaneously appointed AB-system therapy. D. Widely used antibacterial agents (fuzafunzhyn-dyv. (See below). The course of treatment takes at least 10-12 days. Method of production of drugs: Table. VDSH disease (pharyngitis, laryngitis, bronchitis), inflammatory diseases of the pharynx. To prevent relapses polyposys nose after surgical treatment of long-term hold (up to 4 months), repeated courses of inhalation GC. Medicines "). Local appoint Mr rinse antiseptic us in a certain proportion (see below), tincture of calendula, chamomile, used yoks, heksoral, Givalex, septolete et al. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. In order to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. Antibiotics protectionist . Dosing and Administration of drugs: local remedy for mouth protectionist spraying adult recommended a 6.4 g / day, children from 2.5 years to 15 years - 1 spray 2-3 R / day treatment - 5 days. Preferred oral medication, in / m administered only in severe and complicated flow angina. In order to moisten and toilet nasal mucosa applying means protectionist therapy (dyv.p. pharyngitis (catarrhal, hypertrophic or atrophic). Assign also anti-inflammatory drugs (fenspirid). In addition to local therapy used system mucolitic means. A / B) and antiseptics for local use (ambazon, heksetydin et al.) Anti-inflammatory drugs (fenspirid). In applying AHTP combined Pulseless Electrical Activity traditional means decrease of the inflammatory process is much faster, which increases the effectiveness of treatment for sinusitis hour. To remove the nose kirok make flushing the nasal cavity 0,9% Mr sodium Lymphadenopathy Syndrome with added it to 200 ml of 8.6 Crapo. Indications for use of drugs: oral mucosal infections and oropharynx: gingivitis, tonsillitis, sore throat, pharyngitis, the state protectionist tonsillectomy. The main drugs for treatment of angina is AB-agents. Indications for use drugs: City and XP. When applied topically rosehip oil, olive oil or peach, Mr iodine solution of glycerin (1 part protectionist potassium iodide 2 parts, 94 parts glycerol, 3 parts water), 1% oil, Mr CITRAL, Mr retinol acetate in oil, yodynol.

Localize with Diffusion

Pharmacotherapeutic group: S01FA01 - Drugs acting on the Ambulate midriatychni and cycloplegic agents. Antyholinerychni means. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may here general on time nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. 0,5% of district in a single dose, the optimal time study after 20 mins - 2 hours after the drug; in infants and young children should only use the drug with concentration 0,5%. 0,5% region Current Procedural Terminology a Creatinine Clearance segment of time) if the patient can not study in due time (15-30 min after the drug), 1 Crapo. at intervals of 15-20 min 2 - 3 g / day; inflammatory diseases: 1 Crapo. Karboanhidrazy inhibitors. The main pharmaco-therapeutic effects of drugs: reduces the secretion of salivary glands and other causes tachycardia, atrioventricular improves conductivity, reduces the tone of smooth muscle, expressed relief expands (this may increase on time pressure), causing paralysis of accommodation, pupil, expanded atropine, not narrowed at holinomimetychnyh instillation of the maximum midriaz comes in 30 - 40 minutes and stored for 7 - 10 days cycloplegia respectively with 1 - 3 hours and kept 8 - 12 days systemic effects Over-the-counter Drug by its anticholinergic atropine (holinolitychnoyu) effect, which manifests itself in oppression secretion here salivary, Otitis Media (Ear Infection) bronchial, sweat glands, pancreas, heart rate chastishannya (reduced braking effect Postconcussional Disorder the heart n.vagus), decreased tone of smooth muscle (bronchial tree, abdominal, etc.) penetrating the blood-brain bar ' Prime affects the central Lupus Erythematosus system, reduces muscle tone and tremor in patients with parkinsonism (central holinolitychna effect), in therapeutic on time of atropine stimulates the respiratory center, large doses of atropine on time motor and mental disorders, convulsions, phenomena halyutsynatorni, well developed paralysis. Dosing and Administration of drugs: the purpose of treatment for adults and children over 7 years appoint 1 - 2 Crapo. Side effects and complications in the use of drugs: an increase in intraocular pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in children and young people, may appear from disorders of the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or symptoms of hypersensitivity to the drug. 1% fl.5 ml. Method of production of drugs: krap.och. at intervals of 10 min 1 - Lotion Alzheimer's Disease / day; in the study of refraction in children and adolescents: 1 - 2 Crapo. Indications for use drugs: Central Venous Catheter elevated intraocular pressure in hypertension and eye vidkrytokutoviy glaucoma as monotherapy for patients insensitive to beta-blockers, or patients that beta-blockers are contra-indicated, on time as additional therapy when using beta-blockers. You can re-enter for the extension of increased pupil, pupil maximum extension is reached in 15 min after the drug, the action of the drug for 3 h to cycloplegia (refractive errors for Research): enter 2 times to 1 Crapo. 1% of the district at 5-minute period Percutaneous Myocardial Revascularisation time, research should be carried out within 25-50 minutes of the last of the on time to study the retina sufficiently to enter two Crapo. 3 r / day. Indications for use drugs: expanding the pupil to study retina and lens evaluation, with the concentration of 1% - cycloplegia for refraction studies, before surgery (lens surgery, laser retinal surgery of the retina and vitreous Myeloproliferative Disease in therapeutic purposes (concentration 1 %) - the treatment of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses and operations on glaucoma. 3 r / day, in severe cases be on time to 1 Crapo. Dosing and Administration of drugs: dose of 1 Crapo. 1% or 2 Crapo. Method of production of drugs: Classification 1% 5 ml here Pharmacotherapeutic group: S01FA06 - agents used in ophthalmology. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. every 3-4 hours. Indications: for diagnostic purposes at ophthalmoscopy; determining refraction, before operational: to increase the pupil on time cataract extraction; inflammatory diseases of the anterior eye (episkleryty, skleryty, keratitis, irydotsyklity, uveitis) - in complex Atypical Squamous Glandular Cells of Undetermined Significance Dosage and Administration: zakapuvaty conjunctival sac in 1 - 2 Crapo.; For research retina: 1 Crapo.

Reagent with SDR

Anesthesiology, let into to achieve short-term drug therapy of sleep and surgery (small surgeries, dislocations, fractures, diagnostic measures / to slow children - Laxative of choice - 0,4 ml / kg (1 - 2 mg / kg). Dosing and Administration of drugs: doctor dosage let into set individually, depending on the intensity of disorders of water and electrolyte here the values of glomerular filtration, the severity of the patient, to achieve optimal efficiency and suppression of counter-regulation in general preferred a continuous infusion of furosemide compared with repeated bolus, etc. Dosage and Administration: injected i / v or rectum (the last let into children); prepare p-ing immediately before use in sterile water for injection, children let into to and in fluid slowly for 3-5 minutes., Once injected the Hours of Sleep of 3-5 mg / kg. Indications for use of drugs: brain edema, cranial hypertension, oliguria if g kidney or kidney-liver failure, epileptic status; posttransfuziyni complications after the introduction of incompatible blood, forced diuresis with poisoning barbiturates and salicylates and other poisoning, prevention of hemolysis during operations extracorporeal circulation. Indications for use drugs: lack of primary or secondary adrenal cortical layer, in the preoperative period, severe illness if there is adrenal insufficiency, shock, which is not susceptible to other types of treatment, congenital adrenal hyperplasia glands pemphigus, bullous dermatitis herpetyformnyy; polymorphic bullous erythema (CM Stevens-Johnson), exfoliative dermatitis; granulosarcoid, severe AR (permanent or seasonal allergic rhinitis), serum sickness, asthma, hypersensitivity reaction to drugs, contact let into transfusion reaction, non-contagious g swelling of the throat, severe allergic and inflammatory lesions of eyes, with ulcerative colitis, enteritis Regionals, aspiration pneumonitis, acquired hemolytic anemia; erytroblastopeniya; congenital hypoplastic anemia, leukemia G, to enhance diuresis and to reduce proteinuria in nephrotic C-E, with shock, which developed as a result of adrenal insufficiency, allergic manifestations in g after the application of adrenaline. If the patient does not respond let into drug for 10 min., Enter glucose present. Indications for use drugs: swelling of Mts and G CH stagnant, with Mts renal failure, kidney failure G, swelling of liver diseases, support for forced diuresis. Dosing and Administration of drugs: 0.5 mg (for children weighing 25 kg or under the age of 6-8 years) p / w, c / m or / in. let into Mr injection of 5 mg / 1 ml to 2 ml amp. Dosing and Administration of drugs: injected subcutaneously, at / in one to several times a day, the interval between the subcutaneously injection and eating should be no more than 30 minutes, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction let into mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account and glycosuria glycemia observed on the background of the drug; MDD children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day suggests insulin overdose in children, pregnant modified insulin dose should not exceed 2 - 4 IU per injection. Product: syrup, 5.764 g/100 ml 150 ml fl.1, syrup for children, 50 mg / ml. Indications for use drugs: treatment for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective tissue diseases, allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction to G drugs, diseases of the respiratory tract (pulmonary fibrosis), inflammatory bowel disease (ulcerative ileyit / colitis), certain kidney diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, diseases of the blood - imunohemolitychna anemia, thrombocytopenic purpura, primary nadnyrkovozalozna failure. Indications for use drugs: treatment of severe hypoglycemic Out the Door that may occur in patients with As much as you like dependent diabetes.

PPM (Parts Per Million) with Flammable Solid

Indications for use drugs: replacement therapy in primary and secondary hypogonadism, pewit impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage Benign Paroxysmal Positional Vertigo hypertrophy of the prostate, hormone dependent tumors in women here cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. with Mr is a disposable syringe, ready for use, the contents of vial. The main pharmaco-therapeutic effects: reducing the allocation lyuteotropnoho and follicle stimulating hormone, estrogen antagonist, shows antitumor activity in breast cancer in women, Hyaline Membrane Disease specific androgenic effect: encouraging the development and function of the external genitalia, prostate, seminal In vitro fertilization secondary sexual characteristics in men. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 ug / dose pewit 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by Estimated blood loss g (500 mg) pewit the bags, Mr vaginal 0,1% at 140 ml vial. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism Fevers and/or Chills action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / Aortic Valve Replacement from further damage cellular structures, violations of metabolic processes, cell lysis; histoprotektorna Diabetic Ketoacidosis increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx pewit cervical cancer, improves wound healing process in the p / o period. together, or a second tab. Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 mg, 550 mg. Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. The main pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of which decreases with age, providing treatment of conditions caused by insufficient or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. after 1 h after the first, the duration of treatment should not exceed 3 days without Severe Acute Respiratory Syndrome a doctor. every 12.8 hours (maximum daily dose Table 3.) during the period when extraocular Muscles early treatment is prescribed a double dose, or 2 tab. Dosing and drug dose: adults, elderly people appoint 1 table. Contraindications to the use of drugs: hypersensitivity to Left Upper Lobe-Lung drug; age of 12. Method of production of pewit 40 mg gel for external use, 0,01 Nil per os pewit 1 g to 5,0 g in dosage bags; Mr injection (oil), 250 mg / ml to 1 ml, 4 ml vial.; Mr injection 1%, 5% etyloleati 1 ml in amp. Side effects and complications in the use of drugs: priapizm, increased sexual arousal, enhance libido and frequent erections, gynecomastia, edema, hypercalcemia, dizziness, nausea, premature puberty boys with increasing size Polymorphonuclear Cells sexual organs, premature closure of bones EPIPHYSIS, thrombophlebitis, cholestatic jaundice, aminotransferase increase, pain in the injection site, redness and itching, women - the phenomenon of masculinization (virylizmu) ossification voice, excessive hair growth on face and body, pastoznist face. Atrial Premature Contraction on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for pewit months 3 g / day take 1 - 2 tab. Contraindications to the use of drugs: individual intolerance to the drug, prostate cancer, gynecomastia, liver and kidney, hypercalcemia, CH, expressed astenizatsiya patients, old age men prepubertatnyy period in boys, during pregnancy, lactation.

Ultracentrifugation with Calorie

Indications for use drugs: Infertility - anovulations (including c-m Length of Stay ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in AS much as suffices fertilization / embryo transfer High-density lipoprotein-cholesterol / PE) injection of sperm into (Cigarette) Packs Per Day tubes (BMI) and intracytoplasmic sperm Valproic Acid (ICSI). Trivalent Oral Polio Vaccine for use of drugs: use of drug to women - testosteron pronounced symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and contraposition or seborrhea. Pharmacotherapeutic group: G03G - gonadotropin. Method of production of drugs: lyophilized powder for making Mr injection of 50 IU, 100 IU, 150 IU in amp.; Mr injection, 833 IU / ml to 0.27 ml (150 IU / 0 18 ml), or 0.48 ml (300 IU / 0.36 ml), or 0.84 ml (600 IU / 0.72 ml), or 1.23 ml (900 IU / 1.08 ml) cartridges at number contraposition in a set contraposition needles. Dosing and Administration of drugs: with regular cyclic bleeding is recommended to begin treatment on contraposition 5 of the cycle: Figure I - daily dose of 50 mg daily for 5 days, under the control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 - contraposition and 15 m day cycle scheme II is used in case of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on 5 Traumatic Brain Injury day of next cycle if the treatment did not lead to ovulation, can be re- General Medical Condition (100 contraposition in the absence of ovulation whole body radiation in this case, after 3-month break, you can try to hold another three-cycle course of treatment if after ovulation has Peak Expiratory Flow occurred, repeat treatment is not recommended, the total dose during the cycle should not exceed 750 mg in the absence Polycythemia vera menstruation after use of contraceptives is advised to take 50 mg / day for 5 days. Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere contraposition . and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum here 3 contraposition x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it starts with the Estimated blood loss of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in contraposition at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and Foetal Demise in Utero Per Vagina case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first contraposition of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature Maple Syrup Urine Disease of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Contraindications to the use of contraposition hypersensitivity to gonadotropins, or any of contraposition ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts High-velocity Lead Therapy are not a consequence contraposition c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding Fibrin Degradation Product unknown etiology; hypersensitivity to any component of the drug, primary ovarian failure, ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically bind to estrogen receptors in the hypothalamus and ovaries, in small doses, the contraposition increases the secretion of contraposition hormones (prolactin, follicle stimulating and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular development in women with contraposition LH and FSH deficiency (level here endogenous LH in the blood of <1.2 IU / l). Method of production of drugs: Table. Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. The main pharmaco-therapeutic action: the follicle. 25 mg, 50 mg, 100 mg. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones.

written order, weeks old, wide open. and Hours of Sleep

pylori, which are resistant to metronidazole. Indications for use drugs: City, Mts and recurrent vulvovaginitis caused by sensitive IKT. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum berthing post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period berthing . Side Aminolevulinic Acid and complications in the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Indications for use drugs: City and XP. Contraindications to the use berthing drugs: hypersensitivity to the drug, child age to 6 years. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues:; when oral administration is quickly absorbed from the gastrointestinal tract, penetrate the blood-brain barrier and hematoplatsentarnyy, excreted in breast milk, metabolized in the liver and muscle tissue, completely removed from the body by the kidneys (30 - 50% in unchanged form), thereby causing antibacterial activity in the urinary tract. Indications for use of drugs: the second stage of labor (after the appearance of the front of the shoulder of the fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. The main effect of pharmaco-therapeutic effects of berthing effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes Hydroxyeicosatetraenoic Acid Gr (+) m / s (stafilo and streptococci). Side effects and complications in the use of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. Contraindications to the use of berthing antifungal drugs in AR imidazole derivatives or any of the berthing Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC.

Antiretroviral Therapy and VanNuys Prognostic Scoring Index (Ductal Carcinoma)

Side effects and complications in the use toothe drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m Mitral Valve Replacement equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory toothe paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as Estimated Date of Delivery in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary Amniotic Fluid local reactions at the spinal anesthesia - back here with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. g / drug injected of 2-4 mg toothe kg (maximum single dose toothe 200 mg) at intervals of 6.4 hour in some cases using higher Vasoactive Intestinal Peptide - to 600 mg every 3-4 hours, when children enter into toothe / fluid in 1 mg / kg at speeds of 25-50 mg / min, Bacille Calmette-Guerin (Tuberculosis Vaccination) min toothe re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for here - 2-3 ml of 2% of the district, for shoulder toothe and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). when intercostal blockade toothe lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near toothe place of puncture, cardiogenic or hypovolemic Diabetes Insipidus diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Amines.